# McKesson Is Closing a $2.25 Billion Precision Medicine Group Deal

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/49748
Published: 2026-11-06T02:47:11.000Z
Updated: 2026-11-06T02:47:11.000Z
Section: Business

> The deal comes as McKesson’s fiscal 2027 adjusted earnings outlook stands at $45.60 to $46.40 per diluted share.

McKesson Corporation is closing a deal valued at about $2.25 billion for Precision Medicine Group.

McKesson’s [fiscal 2027 adjusted earnings per diluted share outlook](<https://www.tokenpost.com/news/business/49565>) stands at $45.60 to $46.40, up from $44.20 to $45.00 after second-quarter results.



## Links in this article

- [fiscal 2027 adjusted earnings per diluted share outlook](https://www.tokenpost.com/news/business/49565)